| COVID-19 and healthcare impacts | Lifetime | 222 | US 86 | 96.67 |
| Cardiovascular Health and Risk Factors | Lifetime | 218 | US 128 | 97.05 |
| Lipoproteins and Cardiovascular Health | Lifetime | 720 | US 314 | 97.17 |
| Pharmaceutical Economics and Policy | Lifetime | 359 | US 178 | 95.58 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 926 | US 316 | 96.24 |
| Medication Adherence and Compliance | Lifetime | 627 | US 338 | 92.73 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 457 | US 114 | 91.75 |
| Machine Learning in Healthcare | Lifetime | 778 | US 368 | 85.38 |
| Interpreting and Communication in Healthcare | Lifetime | 683 | US 209 | 82.00 |
| Sex and Gender in Healthcare | Lifetime | 503 | US 279 | 79.00 |
| Cardiac Health and Mental Health | 2021-2025 | 12 | US 7 | 98.78 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 14 | US 11 | 98.87 |
| Acute Myocardial Infarction Research | 2021-2025 | 66 | US 28 | 98.78 |
| COVID-19 and healthcare impacts | 2021-2025 | 158 | US 54 | 96.63 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 61 | US 29 | 98.35 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 186 | US 57 | 97.83 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 109 | US 47 | 97.75 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 413 | US 129 | 97.14 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 180 | US 42 | 96.06 |
| Heart Failure Treatment and Management | 2021-2025 | 325 | US 118 | 96.03 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 246 | US 67 | 94.13 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 222 | US 91 | 91.05 |
| Mobile Health and mHealth Applications | 2021-2025 | 364 | US 101 | 91.10 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 65 | US 18 | 85.94 |
| Machine Learning in Healthcare | 2021-2025 | 271 | US 113 | 89.25 |
| Diversity and Career in Medicine | 2021-2025 | 442 | US 358 | 88.05 |
| Medication Adherence and Compliance | 2021-2025 | 245 | US 98 | 86.73 |
| Pharmaceutical Economics and Policy | 2021-2025 | 296 | US 112 | 86.00 |
| Chronic Disease Management Strategies | 2021-2025 | 839 | US 154 | 84.73 |
| Ethics in Clinical Research | 2021-2025 | 540 | US 238 | 80.68 |
| Healthcare Policy and Management | 2021-2025 | 951 | US 648 | 80.59 |
| Sex and Gender in Healthcare | 2021-2025 | 163 | US 60 | 76.67 |
| Patient Satisfaction in Healthcare | 2021-2025 | 997 | US 398 | 68.81 |
| Interpreting and Communication in Healthcare | 2021-2025 | 807 | US 286 | 45.64 |
| Pharmaceutical industry and healthcare | 2021-2025 | 682 | US 370 | 26.50 |
